Galderma, the renowned Swiss skincare giant, has revealed a formidable first-quarter net sales figure of US$1.071 billion, demonstrating a notable 12.4% increase year-on-year. This significant financial update represents the company’s inaugural report since its recent listing on the Swiss stock exchange.
In response to this encouraging announcement, Galderma experienced a surge in its shares by over 3%, signaling a robust vote of confidence from investors regarding the company’s growth trajectory. Although the initial gains moderated subsequently, the substantial sales performance underscores a promising commencement to the fiscal year.
CEO Flemming Ornskov emphasized the comprehensive nature of this growth, spanning diverse regions and product portfolios. Particularly noteworthy was the robust performance observed in the Asia Pacific region, with China emerging as a notable stronghold for the company.
